Oral retinoids can cause birth defects, and women should avoid tretinoin when pregnant or trying to conceive. Avoid prolonged exposure to sunlight.
[T] = Topical; [O] = Oral.
- TRADE NAMES: A-Acido; Aberal; Aberela; Acid A Vit; Acnavit; Acta; Airol; Aknemycin Plus (EM Industries); Alquingel; Alten; ATRA; Atragen; Avita; Avitcid; Avitoin; Cordes VAS; Derm A; Dermairol; Dermojuventus; Epi-Aberel; Eudyna; Relief; Renova (Ortho); Retin-A Micro (Ortho); Retinoic Acid; Retinova; Solage (Galderma); SteiVAA; Stieva-A; Vesanoid (Roche)
- INDICATIONS: Acne vulgaris, skin aging, facial roughness, fine wrinkles, hyperpigmentation [T], acute promyelocytic leukemia [O]
- SYNONYM: all-trans-retinoic acid; ATRA
- CLASS: Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor), Retinoid
- HALF-LIFE: 0.5–2 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aldesleukin, Bexarotene - PREGNANCY: category B (topical), category C (oral), category D in third trimester
- See adverse reactions attributed to class:
Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor)
Please login to view the rest of this drug profile.
Page last updated 04/10/2024
